WILLIAM BRADLEY: Open Payments
NPI 1649375940 · SIKESTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 54 payments from 13 companies in 2025. Trend: 2023 $730 · 2024 $562 · 2025 $1,149
Food & beverage: $1,149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $395 |
| AstraZeneca Pharmaceuticals LP | 6 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $115 |
| Boston Scientific Corporation | 1 | $92 |
| Amgen Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $59 |
| Dexcom, Inc. | 3 | $52 |
| Novo Nordisk Inc | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $33 |
Products named: VRAYLAR, BREZTRI, JARDIANCE, Lumenis Pulse 120H, REXULTI, MOUNJARO, OTEZLA, Dexcom G6 Transmitter.
Industry payments across MO — which companies pay providers there.
